Stock listing
NASDAQ:ELEV Elevation Oncology Inc Stock
Follow Elevation Oncology Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ELEV
$0.365 USD
Close on Jul 22, 2025 · No longer trades
- Lowest – highest close
- $0.233 – $16.110 USDSince Jun 25, 2021 · lowest Apr 8, 2025 · highest Jul 12, 2021
Delisted NASDAQ:ELEV no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ELEV
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Elevation Oncology Inc on 6ix
- Calls
- 1 call with a replay · 1 with a transcript · latest Aug 6, 2024
- Decks
- 3 decks · latest Apr 17, 2023
Events
| Call | When | Status |
|---|---|---|
| Elevation Oncology (ELEV) Q2 2024 Earnings Call | Tue, Aug 06, 2024 · 8:30 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (April 2023) | Technical | 20 slides | Apr 17, 2023 |
| Corporate Update (July 2022) | Corporate update | 16 slides | Jul 28, 2022 |
| Corporate Update (May 2022) | Corporate update | 21 slides | May 27, 2022 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alan Sandler Other companies: Revolution Medicines, Inc. (Chief Development Officer · Since at least Nov 5, 2025); ALX Oncology Holdings Inc. (Director · Since at least Aug 5, 2024); Zai Lab Ltd. (Head of Global Dev., Oncology · Jan 1, 2021 – Jun 25, 2022 · Past) | Director · Since at least Feb 29, 2024 |
| David Dornan Other companies: Whitehawk Therapeutics, Inc. (Chief Scientific Officer · Since at least Feb 18, 2025); Bolt Biotherapeutics, Inc. (Chief Scientific Officer · Feb 4, 2021 – Feb 18, 2022 · Past) | CHIEF SCIENTIFIC OFFICER · Mar 14, 2022 – Feb 15, 2025 · Past |
| Colin Walsh Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026) | Director · Jun 24, 2021 – Jun 16, 2023 · Past |
| Julie M Cherrington Other companies: Vaxart, Inc. (Director · Aug 20, 2021 – Aug 4, 2022 · Past) | Director · Since at least Feb 29, 2024 |
| Valerie Jansen Other companies: OnKure Therapeutics, Inc. (Director · Since at least Oct 4, 2024) | CHIEF MEDICAL OFFICER · Jan 6, 2023 – Feb 15, 2025 · Past |
| Darcy Mootz | Director · Since at least Jan 18, 2024 |
| Shawn Leland | President, CEO, Director · Jun 24, 2021 – Feb 14, 2022 · Past |
| Tammy Furlong | CHIEF FINANCIAL OFFICER · Since at least Jul 12, 2023 |
Log in to ask 6ix AI your own questions about Elevation Oncology Inc.